• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,786
2,308
2,237
1,865
1,727

COUNTRY

1,033
871
272
254
210

CATEGORIES

  • 858
  • 186
  • 681
  • 1,127
  • 398
  • 270
  • 255
  • 66
  • 382
  • 725
  • 1,339
  • 1,356
  • 626
  • 884
  • 1,706
  • 2,689
  • 507
  • 732
  • 0
  • 93

PRICE

7,470
12,515
20,254
26,483

PUBLISHED

2,902
3,767
8,292
26,483

PRODUCT TYPE

21,609
2,901
872
827
164
44
21
21
17
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Rabies Global Clinical Trials Review, H2, 2013

Rabies Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Rabies Global Clinical Trials Review, H2, 2013" provides data on the Rabies clinical trial scenario. This report...

August 2013
FROM

Pruritus Global Clinical Trials Review, H2, 2013

Pruritus Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Pruritus Global Clinical Trials Review, H2, 2013" provides data on the Pruritus clinical trial scenario This report...

August 2013
FROM
The World OTC Medicine Market Report 2013 The World OTC Medicine Market Report 2013 - Product Thumbnail Image

The World OTC Medicine Market Report 2013

Covering 72 country markets, worldwide, this new report is today's essential business resource for all pharmaceutical executives with an interest in the global OTC medicine market! With the increasing...

August 2013
FROM

2013 Germany Procedure Volumes Database

This in-depth procedure volumes database quantifies current and forecast (2010-2017) procedure volumes across a spectrum of medical segments in some of the most promising and emerging markets Extensive...

August 2013
FROM

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022 Summary Overweight and obesity are characterized by abnormal or excessive fat accumulation in the body, which can increase the...

August 2013
FROM

Cardiovascular Inflammation Global Clinical Trials Review, H2, 2013

Cardiovascular Inflammation Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Cardiovascular Inflammation Global Clinical Trials Review, H2, 2013" provides data on the Cardiovascular...

August 2013
FROM
Top ICT spenders in the Canadian Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 Top ICT spenders in the Canadian Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013 - Product Thumbnail Image

Top ICT spenders in the Canadian Pharmaceutical Industry - Estimated ICT budget breakdowns in 2013

Synopsis This report illustrates how Kable expects the top ICT spenders in Canada Pharmaceutical industry to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware,...

August 2013
FROM

Septic Shock Global Clinical Trials Review, H2, 2013

Septic Shock Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Septic Shock Global Clinical Trials Review, H2, 2013" provides data on the Septic Shock clinical trial scenario....

August 2013
FROM

PharmaPoint: Meningococcal Vaccines - Current and Future Players

PharmaPoint: Meningococcal Vaccines - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Meningococcal Vaccines - Current and Future Players”. The report is...

August 2013
FROM
The World Prescription Drug Market Report The World Prescription Drug Market Report - Product Thumbnail Image

The World Prescription Drug Market Report

The back-lash of the 2007/2008 global financial crisis led to pressure from governments reducing healthcare budgets This, in turn, left the global prescription market feeling the pinch But with the...

August 2013
FROM

Partnerships, Licensing, Investments and M&A Deals and Trends for July 2013 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for July 2013 in Pharmaceuticals Summary Our “Partnerships, Licensing, Investments and M&A Deals and Trends for July 2013 in Pharmaceuticals”...

August 2013
FROM

Bacteriuria Global Clinical Trials Review, H2, 2013

Bacteriuria Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Bacteriuria Global Clinical Trials Review, H2, 2013" provides data on the Bacteriuria clinical trial scenario....

August 2013
FROM

Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2013

Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2013" provides data on the Duchenne...

August 2013
FROM

PharmaFocus: HIV - R&D Strategies towards Cure and Prevention

PharmaFocus: HIV - R&D Strategies towards Cure and Prevention Summary It has been 30 years since the discovery that HIV is the causative agent of AIDS, and yet no preventative vaccine or cure that...

August 2013
FROM

PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update

PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium...

August 2013
FROM

Autism - Pipeline Review, H2 2013

Autism - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Autism - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2013

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2013', provides an...

August 2013
FROM

Anemia - Pipeline Review, H2 2013

Anemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Anemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

August 2013
FROM

Alzheimer's Disease - Pipeline Review, H2 2013

'Alzheimer's Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Alzheimer's Disease,...

August 2013
FROM

Dyslipidemia - Pipeline Review, H2 2013

Dyslipidemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Dyslipidemia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

August 2013
FROM
Loading Indicator

Our Clients

Our clients' logos